GeneDx (WGS) announced Mimi Lee as chief precision medicine officer. As chief precision medicine officer, Lee will lead GeneDx’s work to empower customizable precision medicine as the standard of care, leveraging the power of genomics to predict, prevent, and optimize health outcomes throughout a person’s lifetime. Lee joins GeneDx from the Advanced Research Projects Agency for Health, where she designed and directed public-private programs.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WGS:
- GeneDx selected by Florida State University as partner for Sunshine Genetics Act
- DASH, DE, BABA: Cathie Wood Loads Up on DoorDash, Deere & Alibaba, Trims Stakes in ADPT and Others
- GeneDx appoints Gurry as Chief Business Officer
- Eli Lilly’s (LLY) AI Chief Joins the Board of GeneDx
- GeneDx Holdings Appoints Thomas Fuchs to Board